Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q3 FY2018 Earnings Presentation
11 slides from Phibro Animal Health's earnings presentation, May 8, 2018
Slide 1: Phibro Animal Health Corporation Third Quarter Webcast and Conference Call
Phibro Animal Health Corporation Third Quarter – March 31, 2018 U.S. toll-free +1-877-853-5634 Webcast and Conference Call International toll +1-315-625-6893 May 8, 2018 Conference ID: 69676216 May 8, 2018 Webcast and Conference Call
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 3 May 8, 2018 Webcast and Conference Call
Slide 4: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude: - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and accrued interest
Slide 5: Highlights
Highlights Q3 – March 2018 For the three months ended 2018 2017 Change Sales growth across all segments March 31 (in millions, except per share amounts and percentages) Net income and diluted EPS declined - Insurance gain of $7.5M in the prior year Net sales $ 208.9 $ 189.9 $ 19.0 10% - Operating in
Slide 6: Selected Line Items
Selected Line Items Q3 – March 2018 For the three months ended March 31 2018 2017 Change Adjusted gross profit increased on volume growth (in millions, except per share amounts and percentages) and favorable mix. Net sales $ 208.9 $ 189.9 $ 19.0 10% Adjusted gross profit 70.4 61.9 8.5 14% Adjusted S
Slide 7: Animal Health
Animal Health Q3 – March 2018 Sales Animal Health For the three months ended – Nutritional specialties: Volume growth in dairy and poultry 2018 2017 Change industries in various international countries and in the U.S. March 31 (in millions, except percentages) – Vaccines: Volume growth in internatio
Slide 8: Other Segments
Other Segments Q3 – March 2018 For the three months ended 2018 2017 Change March 31 (in millions, except percentages) Mineral Nutrition Mineral Nutrition Net sales $ 62.9 $ 57.2 $ 5.8 10% – Sales growth on higher average selling prices due to increased commodity pricing Adjusted EBITDA $ 5.4 $ 4.3 $
Slide 9: Capitalization, Capital Allocation and Guidance
Capitalization, Capital Allocation and Guidance March 31, 2018 2.5x leverage ratio at March 31, 2018 - $311 million total debt - $125 million LTM Adjusted EBITDA $76 million cash and short-term investments on hand at March 31, 2018 $18 million source of cash before financing for the March 2018 quart
Slide 10: Q&A Session
Q&A Session 10 May 8, 2018 Webcast and Conference Call
Slide 11: © 2018 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2018 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; AB20; Animate; Aviax; Cellerate Yeast Solutions; Gemstone; Lactrol; Magni-Phi; Mecadox; MJPRRS; Neo-Terra; Neo- Terramycin; Neo-TM; Nicarb; OmniGen-AF; PAQ-Gro; Stafa
Phibro Animal Health — Q3 FY2018 Earnings Presentation on 6ix